Logo
  • About
  • Technology
  • News
  • Contact
Logo
  • About
  • Technology
  • News
  • Contact
07
Jan
2019

7-11 January 2019: Meet Insusense Therapeutics in San Francisco at this year’s JP Morgan biotech conference

News

Come meet us at DK Bio 2019
20. February 2019
Insusense Therapeutics website launches
4. January 2019
Paul Little, Operating Partner in Lundbeckfonden Emerge, replaces Christian Elling as CEO of Insusense Therapeutics
1. October 2018
Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics
20. October 2015

About Us

InsuSence Therapeutics is a product-focused biotechnology company based on novel breakthrough science in diabetes biology, which has the potential to quantum leap to important new Type 2 diabetes therapeutics.

News

Come meet us at DK Bio 2019
20. February 2019
Insusense Therapeutics website launches
4. January 2019
Paul Little, Operating Partner in Lundbeckfonden Emerge, replaces Christian Elling as CEO of Insusense Therapeutics
1. October 2018

Contact

Insusense ApS
c/o Lundbeckfonden
Scherfigsvej 7
DK-2100 Copenhagen

  • Privacy Policy
Copyright © InsuSense Therapeutics, All Rights Reserved.